Buy Nkarta, Inc. Stock | NKTX Stock Price & Latest News | Public
NKTX

Nkarta, Inc.

$0.00 (0.00%)Today

    About NKTX

    Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.58
    -1.17
    -1.75
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.41

    Actual EPS
    Q3 2020

    Stats

    Market Cap$768,31M
    Volume2,47k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$58.69
    1 Year Low$23.44
    Open$23.81
    High$24.01
    Low$23.47

    Buy any stock with any amount of money.

    Download the App
    Download the app